BeyondSpring (BYSI) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.56, -3.92% vs the prior close of $0.58.
- Volume 11.17K shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BYSI slides 3.9% to $0.56, a 52-week low, 4 down days in a row. Closed at $0.56, -3.92% vs the prior close of $0.58. Day range $0.56–$0.60, opened at $0.58.
BYSI daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — BYSI slides 3.9% to $0.56, a 52-week low, 4 down days in a row
- Closed at $0.56, -3.92% vs the prior close of $0.58. Day range $0.56–$0.60, opened at $0.58.
- Volume was 11.17K shares, 0.0x its 50-day average of 1.09M — lighter than usual.
- Price is -22.0% vs its 50-day average ($0.72) and -57.9% vs its 200-day average ($1.33).
- 52-week range $0.56–$2.44; today's close sits at 0% of that range, 77.1% below the 52-week high.
- That makes 4 straight losses.
Oct 15, 2026 — BYSI dips 0.9% to $0.58, a 52-week low, 3 down days in a row
- Closed at $0.58, -0.85% vs the prior close of $0.59. Day range $0.57–$0.62, opened at $0.59.
- Volume was 35.10K shares, 0.0x its 50-day average of 1.09M — lighter than usual.
- Price is -19.5% vs its 50-day average ($0.72) and -56.3% vs its 200-day average ($1.33).
- 52-week range $0.57–$2.44; today's close sits at 1% of that range, 76.1% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 — BYSI slides 3.3% to $0.59, a 52-week low
- Closed at $0.59, -3.29% vs the prior close of $0.61. Day range $0.57–$0.63, opened at $0.60.
- Volume was 36.50K shares, 0.0x its 50-day average of 1.09M — lighter than usual.
- Price is -19.7% vs its 50-day average ($0.73) and -56.2% vs its 200-day average ($1.34).
- 52-week range $0.57–$2.44; today's close sits at 1% of that range, 75.9% below the 52-week high.
Oct 13, 2026 — BYSI dips 1.5% to $0.61
- Closed at $0.61, -1.46% vs the prior close of $0.62. Day range $0.60–$0.64, opened at $0.62.
- Volume was 53.40K shares, 0.0x its 50-day average of 1.09M — lighter than usual.
- Price is -17.8% vs its 50-day average ($0.74) and -54.9% vs its 200-day average ($1.35).
- 52-week range $0.57–$2.44; today's close sits at 2% of that range, 75.1% below the 52-week high.
- SEC filings that day: 8-K.
Oct 12, 2026 — BYSI rises 1.7% to $0.62
- Closed at $0.62, +1.65% vs the prior close of $0.61. Day range $0.59–$0.66, opened at $0.60.
- Volume was 38.00K shares, 0.0x its 50-day average of 1.09M — lighter than usual.
- Price is -17.9% vs its 50-day average ($0.75) and -54.4% vs its 200-day average ($1.35).
- 52-week range $0.57–$2.44; today's close sits at 3% of that range, 74.8% below the 52-week high.
Oct 9, 2026 — BYSI dips 0.5% to $0.61, a 1-month low, 6 down days in a row
- Closed at $0.61, -0.49% vs the prior close of $0.61. Day range $0.59–$0.67, opened at $0.59.
- Volume was 57.70K shares, 0.1x its 50-day average of 1.09M — lighter than usual.
- Price is -20.3% vs its 50-day average ($0.76) and -55.4% vs its 200-day average ($1.36).
- 52-week range $0.57–$2.44; today's close sits at 2% of that range, 75.2% below the 52-week high.
- That makes 6 straight losses.
Oct 8, 2026 — BYSI slides 5.6% to $0.61, a 1-month low, 5 down days in a row
- Closed at $0.61, -5.58% vs the prior close of $0.64. Day range $0.60–$0.67, opened at $0.63.
- Volume was 60.20K shares, 0.1x its 50-day average of 1.09M — lighter than usual.
- Price is -21.0% vs its 50-day average ($0.77) and -55.4% vs its 200-day average ($1.36).
- 52-week range $0.57–$2.44; today's close sits at 2% of that range, 75.0% below the 52-week high.
- That makes 5 straight losses.
Oct 7, 2026 — BYSI slides 6.8% to $0.64, 4 down days in a row
- Closed at $0.64, -6.79% vs the prior close of $0.69. Day range $0.63–$0.69, opened at $0.68.
- Volume was 101.70K shares, 0.1x its 50-day average of 1.09M — lighter than usual.
- Price is -17.5% vs its 50-day average ($0.78) and -53.0% vs its 200-day average ($1.37).
- 52-week range $0.57–$2.44; today's close sits at 4% of that range, 73.6% below the 52-week high.
- That makes 4 straight losses.
Oct 6, 2026 — BYSI slides 12.0% to $0.69, 3 down days in a row
- Closed at $0.69, -11.96% vs the prior close of $0.79. Day range $0.69–$0.77, opened at $0.76.
- Volume was 116.30K shares, 0.1x its 50-day average of 1.08M — lighter than usual.
- Price is -12.7% vs its 50-day average ($0.79) and -49.8% vs its 200-day average ($1.38).
- 52-week range $0.57–$2.44; today's close sits at 7% of that range, 71.6% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 8-K.
Oct 5, 2026 — BYSI ends flat (-0.1%) to $0.79
- Closed at $0.79, -0.13% vs the prior close of $0.79. Day range $0.72–$0.83, opened at $0.72.
- Volume was 94.30K shares, 0.1x its 50-day average of 1.08M — lighter than usual.
- Price is -2.1% vs its 50-day average ($0.80) and -43.3% vs its 200-day average ($1.39).
- 52-week range $0.57–$2.44; today's close sits at 12% of that range, 67.8% below the 52-week high.
Oct 2, 2026 — BYSI slides 3.3% to $0.79
- Closed at $0.79, -3.32% vs the prior close of $0.81. Day range $0.78–$0.85, opened at $0.79.
- Volume was 69.40K shares, 0.1x its 50-day average of 1.08M — lighter than usual.
- Price is -2.7% vs its 50-day average ($0.81) and -43.4% vs its 200-day average ($1.39).
- 52-week range $0.57–$2.44; today's close sits at 12% of that range, 67.7% below the 52-week high.
- SEC filings that day: 8-K.
BYSI latest news & SEC filings
Every SEC filing by or about BYSI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Oct 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.01 — Completed an acquisition or sale of assets.
Oct 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Sep 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 8.01 — Reported other events the company considers important.
Sep 29, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Sep 3, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Sep 3, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Sep 3, 2026 · Form ARS — Annual report to shareholders
Annual report to shareholders
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$849.00K (prior year -$1.81M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.02 (prior year -$0.04) (loss narrowed vs Jun 30, 2025)
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 6, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Things to know before you trade BYSI
- Last results release: Aug 14, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 25, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 13, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 6.56% (largest 44.1%). That is a volatile stock.
- Liquidity: about 586.05K shares (≈$327.72K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.56 vs a range of $0.56–$2.44 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Capital China Life Sciences Usd Fund Ii, L.P. Decheng sold 45,513 shares on Oct 17, 2025.
- Latest filings: 8-K Oct 13, 2026; 8-K Oct 6, 2026; 8-K Oct 2, 2026.
- Share count: 41.12M shares outstanding (Jul 31, 2026), +2.0% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
BYSI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.58 | 0.60 | 0.56 | 0.56 | 11.17K |
| Oct 15, 2026 | 0.59 | 0.62 | 0.57 | 0.58 | 35.10K |
| Oct 14, 2026 | 0.60 | 0.63 | 0.57 | 0.59 | 36.50K |
| Oct 13, 2026 | 0.62 | 0.64 | 0.60 | 0.61 | 53.40K |
| Oct 12, 2026 | 0.60 | 0.66 | 0.59 | 0.62 | 38.00K |
| Oct 9, 2026 | 0.59 | 0.67 | 0.59 | 0.61 | 57.70K |
| Oct 8, 2026 | 0.63 | 0.67 | 0.60 | 0.61 | 60.20K |
| Oct 7, 2026 | 0.68 | 0.69 | 0.63 | 0.64 | 101.70K |
| Oct 6, 2026 | 0.76 | 0.77 | 0.69 | 0.69 | 116.30K |
| Oct 5, 2026 | 0.72 | 0.83 | 0.72 | 0.79 | 94.30K |
| Oct 2, 2026 | 0.79 | 0.85 | 0.78 | 0.79 | 69.40K |
| Oct 1, 2026 | 0.76 | 0.84 | 0.72 | 0.81 | 68.40K |
| Sep 30, 2026 | 0.70 | 0.85 | 0.70 | 0.77 | 266.20K |
| Sep 29, 2026 | 0.80 | 0.83 | 0.57 | 0.77 | 2.42M |
| Sep 28, 2026 | 0.75 | 1.14 | 0.75 | 1.12 | 8.20M |
| Sep 25, 2026 | 0.72 | 0.79 | 0.72 | 0.78 | 15.60K |
| Sep 24, 2026 | 0.73 | 0.77 | 0.72 | 0.73 | 17.60K |
| Sep 23, 2026 | 0.75 | 0.76 | 0.71 | 0.73 | 13.40K |
| Sep 22, 2026 | 0.73 | 0.76 | 0.73 | 0.74 | 15.70K |
| Sep 21, 2026 | 0.73 | 0.77 | 0.72 | 0.74 | 32.00K |
About BeyondSpring
BeyondSpring (BYSI) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in FLORHAM PARK, NJ. Fiscal year ends December 31. SEC CIK 1677940.
BYSI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Brendan Delaney | Director | Apr 3, 2026 |
| Patrick Fabbio | Director | Apr 3, 2026 |
| Lan Huang | Chief Executive Officer | May 15, 2026 |
| Matthew Kirkby | Director | Apr 8, 2026 |
| Jiangwen Majeti | Director | Jul 6, 2026 |
| Sihai Xu | Director | Apr 3, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Lan Huang | Chief Executive Officer | May 15, 2026 |
| Na (Nl) Li | Chief Financial Officer | Jul 6, 2026 |
| Yingjuan June Lu | Chief Scientific Officer | Apr 3, 2026 |
| Min Qiu | Chief Executive Officer | Jul 6, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Oct 17, 2025 | Capital China Life Sciences Usd Fund Ii, L.P. Decheng | Sale | 45,513 | $1.76 |
| Oct 17, 2025 | Capital China Life Sciences Usd Fund Ii, L.P. Decheng | Sale | 45,513 | $1.76 |
| Oct 17, 2025 | Capital China Life Sciences Usd Fund Iii, L.P. Decheng | Sale | 45,513 | $1.76 |
| Oct 17, 2025 | Capital China Life Sciences Usd Fund Iii, L.P. Decheng | Sale | 45,513 | $1.76 |
| Oct 17, 2025 | Capital Management Iii (Cayman), Llc Decheng | Sale | 45,513 | $1.76 |
| Oct 17, 2025 | Capital Management Iii (Cayman), Llc Decheng | Sale | 45,513 | $1.76 |
| Oct 17, 2025 | Capital Management Ii (Cayman), Llc Decheng | Sale | 45,513 | $1.76 |
| Oct 17, 2025 | Capital Management Ii (Cayman), Llc Decheng | Sale | 45,513 | $1.76 |
| Oct 17, 2025 | Capital Global Healthcare Gp, Llc Decheng | Sale | 45,513 | $1.76 |
| Oct 17, 2025 | Capital Global Healthcare Gp, Llc Decheng | Sale | 45,513 | $1.76 |
| Oct 17, 2025 | Xiangmin Cui | Sale | 45,513 | $1.76 |
| Oct 17, 2025 | Xiangmin Cui | Sale | 45,513 | $1.76 |
| Oct 17, 2025 | Capital Global Healthcare Fund (Master), Lp Decheng | Sale | 45,513 | $1.76 |
| Oct 17, 2025 | Capital Global Healthcare Fund (Master), Lp Decheng | Sale | 45,513 | $1.76 |
| Oct 17, 2025 | Capital China Life Sciences Usd Fund Ii, L.P. Decheng | Sale | 45,513 | $1.76 |
BYSI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-1.01M | -0.02 | $-19.77M |
| Dec 31, 2024 | — | $-11.12M | -0.28 | $-16.44M |
| Dec 31, 2023 | — | $-21.03M | -0.54 | $-16.47M |
Latest balance sheet: total assets $14.61M, total liabilities $50.63M, cash $2.70M (as of Jun 30, 2026).
BYSI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 14, 2026 | 8-K Item 2.02 (results) | $0.84 |
| May 13, 2026 | 8-K Item 2.02 (results) | $1.45 |
| Mar 25, 2026 | 8-K Item 2.02 (results) | $1.68 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $2.12 |
| Aug 13, 2025 | 8-K Item 2.02 (results) | $2.00 |
| May 12, 2025 | 8-K Item 2.02 (results) | $1.65 |
| Mar 27, 2025 | 8-K Item 2.02 (results) | $1.50 |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on BYSI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.